Finally listened to the Q1 announcement webcast over the weekend
- interesting to note that MSB expects both phase 3 readouts within a couple of weeks.
- webcast also seems to suggest that COVID ARDS readouts will trigger a significant proportion of the $505 million pre-commercialisation payments. Along those lines, I'd be expecting a milestone payment to be triggered once we get the 60% interim irrespective as to whether it is overwhelming efficacy or not (just needs to pass futility)
If we assumed COVID ARDS was $200 million of the 505 million, then it might be
- 60% interim (passes futility) - $20 million
- trial completion/overwhelming effiacy $50 million
- EUA - $50 million
- final BLA approval - $ 50 million
- additional markets ie EU - $30 million
All cause ARDS would be similar but with additional milestones along the lines of commencement of phase 3, earlier interims etc
Anyone have a sneaky suspicion that MSB might try to time one of the announcements with tomorrows AGM?![]()
- Forums
- ASX - By Stock
- Ann: Mesoblast Corporate Update and Financial Results Webcast
Finally listened to the Q1 announcement webcast over the weekend...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43856 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 66000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 52505 | 1.100 |
1 | 4552 | 1.095 |
3 | 60574 | 1.090 |
3 | 31716 | 1.085 |
2 | 14000 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 66000 | 1 |
1.115 | 80808 | 1 |
1.120 | 88882 | 4 |
1.125 | 74996 | 5 |
1.130 | 111884 | 6 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |